Vaccines for the elderly need to be introduced into the immunization program in India

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 8, 2014, Pages 2468-2470

  Verma, Ramesh ^a   Khanna, Pardeep ^a   Chawla, Suraj ^b  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SHKM Government Medical College   (India)

Author keywords

Death; Disability; Infection; Pneumonia; Vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; VACCINE; VARICELLA ZOSTER VACCINE;

ACTIVE IMMUNIZATION; COMMUNICABLE DISEASE; GERIATRIC CARE; HEALTH PROGRAM; HERPES ZOSTER; HUMAN; INDIA; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; MORTALITY; NON COMMUNICABLE DISEASE; NOTE; PREVENTIVE MEDICINE; PUBLIC HEALTH; TETANUS; AGED; COMMUNICABLE DISEASES; FEMALE; INCIDENCE; MALE; PREVENTIVE HEALTH SERVICE; UTILIZATION; VACCINATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMMUNICABLE DISEASES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INDIA; MALE; VACCINATION;

EID: 84908374410     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29254     Document Type: Note

References (16)

1. National Program for Health Care of the Elderly (NPHCE). Operational Guidelines 2011. Ministry of health and family welfare, New Delhi: Director General of Health Services, MOHFW, Government of India; 2011.
2. Situation Analysis of the Elderly in India. Central Statistics Office, New Delhi: Central Statistics Office Ministry of Statistics and Programme Implementation, Government of India; 2011.
3. Trends in Causes of Death Among Older Persons in the United States. National Center for Health Statistics. Trends in Health and Aging. Available from: http://www.cdc.gov/nchs/ agingact.htm.
4. Mukherjee T, Pramod K, Srinivasan G. Journal of The Indian Academy of Geriatrics 2005; 2:61-4
5. Isahak I; Steering Committee for Prevention and Control of Infectious Diseases in Asia. Adult immunization - a neglected issue in Southeast Asia. Southeast Asian J Trop Med Public Health 2000; 31:173-84; PMID:11023089
6. Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010; 16:402-10; PMID:20132251; http://dx.doi.org/10.1111/j.1469-0691.2010.03182.x
7. Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, Rückinger S, Dagan R, Adegbola R, Cutts F, Johnson HL, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51:692-9; PMID:20715907; http://dx.doi.org/10.1086/655828
8. World Health Organization. Weekly Epidemiological Record. WHO Position Paper 2005; 33:277-88
9. Viboud C, Miller M. Health benefits of universal influenza vaccination strategy. PLoS Med 2008; 5:e216; PMID:18959475; http://dx.doi.org/10.1371/journal.pmed.0050216
10. Reid PM, Brown D, Coni N, Sama A, Waters M. Tetanus immunisation in the elderly population. J Accid Emerg Med 1996; 13:184-5; PMID:8733655; http://dx.doi.org/10.1136/emj.13.3.184
11. Alagappan K, Rennie W, Kwiatkowski T, Falck J, Silverstone F, Silverman R. Seroprevalence of tetanus antibodies among adults older than 65 years. Ann Emerg Med 1996; 28:18-21; PMID:8669732; http://dx.doi.org/10.1016/S0196-0644(96)70132-4
12. Kretsinger K, Broder K, Cortese M, et al. Preventing tetanus, diphtheria, and pertussis among adults use of tetanus toxoid, reduced diphtheria toxoid and acellular pertusis vaccine. MMWR Morb Mortal Wkly Rep 2006; 55:1-33; PMID:16410759
13. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1):S1-26; PMID:17143845; http://dx.doi.org/10.1086/510206
14. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000; 321:794-6; PMID:11009518; http://dx.doi.org/10.1136/bmj.321.7264.794
15. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al.; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84; PMID:15930418; http://dx.doi.org/10.1056/NEJMoa051016
16. Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007; 44:1280-8; PMID:17443464; http://dx.doi.org/10.1086/514342